1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Cancer of Cervix in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gutiérrez-Iglesias, G; Hurtado, Y; López-Marure, R; Palma-Lara, I | 1 |
1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Cancer of Cervix
Article | Year |
---|---|
Resistance to the antiproliferative effect induced by a short-chain ceramide is associated with an increase of glucosylceramide synthase, P-glycoprotein, and multidrug-resistance gene-1 in cervical cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Genes, MDR; Glucosyltransferases; Glycosylation; Humans; Lactosylceramides; Morpholines; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2014 |